Skip to content

Drug interactions

Ezogabine + Pasireotide

Severity: Major

Ezogabine and Pasireotide: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide can prolong the QT interval and cause bradycardia, and ezogabine also prolongs QT. The combination may raise the risk of torsades de pointes.

What this interaction means in plain words

Ezogabine and Pasireotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ezogabine belongs to Central Nervous System; Pasireotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive QT prolongation.

What to do

Obtain a baseline ECG and monitor QTc during therapy, and correct hypokalemia and hypomagnesemia. Avoid the combination if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ezogabine and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Ezogabine with Pasireotide?

MediHelp rates the interaction as major. Ezogabine and Pasireotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pasireotide can prolong the QT interval and cause bradycardia, and ezogabine also prolongs QT. The combination may raise the risk of torsades de pointes.

How serious is the interaction between Ezogabine and Pasireotide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor QTc during therapy, and correct hypokalemia and hypomagnesemia. Avoid the combination if QTc becomes markedly prolonged.

What other medicines interact with Ezogabine?

MediHelp also lists interactions of Ezogabine with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Ezogabine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in